Subject: Germany Clears Vestar Drug
Date: Published: 10/14/92 (22 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    Germany Clears Vestar Drug

    SAN DIMAS, Calif.  -- Vestar Inc. said German regulatory
 authorities approved the commercial sale of the company's antifungal
 drug AmBisome in that nation.
    The pharmaceutical concern said that commercial sale of AmBisome
 will begin immediately in Germany, "the largest pharmaceutical
 market in Europe."  The approval is a "significant milestone in our
 strategic marketing" of AmBisome.
    The news pushed up the price of Vestar's stock, which finished at
 $12.25 a share, up $1.25, in national over-the-counter trading.
    AmBisome, a treatment for cancer as well as for AIDS and other
 conditions related to damaged immune systems, has full marketing
 approval in the United Kingdom, Sweden and Ireland, Vestar said.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]